The CRISPR gene editing technology has revolutionized the field of molecular biology, offering unprecedented precision and efficiency in genetic manipulation. With its vast potential in various ...

Gene editing and many other useful biotechnology tools came from studies of bacteria fighting off viral invaders. But ...

Market Overview: The European CRISPR gene editing market has experienced significant expansion, driven by advancements in biotechnology and increasing investment in genetic research. With a compound ...

The recent wave of layoffs and financial troubles at CRISPR-focused startups should not tarnish the promise of CRISPR.

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

In a new development, researchers have successfully created an efficient two-line system for hybrid seed production in ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...

Vertex Pharmaceuticals has grown from a $7.5 billion market cap to over $120 billion as it’s commercialized several products.

New Delhi: US researchers have used modern technology CRISPR interference to identify a new set of genes that contribute to ...

RAPID-CRISPR test quickly and accurately diagnoses acute promyelocytic leukemia, a rare and aggressive blood cancer, with ...

CRISPR Therapeutics (NasdaqGM:CRSP) witnessed a notable 25% gain over the past week, gaining traction amid an executive departure. The announcement of COO Julianne Bruno’s exit could have influenced ...

Gene editing technologies have cemented their place as a valued method in the biological toolkit used by researchers around the globe.